Primary pulmonary lymphoepithelioma‐like carcinoma treated with immunotherapy: A case report and literature review

Here, we report a case of metastatic Epstein–Barr virus (EBV)‐related primary pulmonary lymphoepithelioma‐like carcinoma (PPLELC) in a young, nonsmoking female who responded well to treatment with two types of immune checkpoint inhibitors (ICIs). This is the first case report of a favorable outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Archwamety, Anita, Ruangchira‐urai, Ruchira, Akewanlop, Charuwan, Korphaisarn, Krittiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436678/
https://www.ncbi.nlm.nih.gov/pubmed/35830974
http://dx.doi.org/10.1111/1759-7714.14580
Descripción
Sumario:Here, we report a case of metastatic Epstein–Barr virus (EBV)‐related primary pulmonary lymphoepithelioma‐like carcinoma (PPLELC) in a young, nonsmoking female who responded well to treatment with two types of immune checkpoint inhibitors (ICIs). This is the first case report of a favorable outcome to ICIs in the late‐line treatment of advanced PPLELC patients with programmed cell death‐ligand 1 (PD‐L1) expression.

Ejemplares similares